ADVANCED

VIA KIT

Home / Products / VIA Kits / Advanced VIA Kit

ADVANCED VIA KIT

Safe and reliable.

Dalrada Health’s enhanced single-use disposable advanced VIA kit features components manufactured in FDA-approved facilities that are sterilized and standardized in order to prevent cross-contamination with the goal of achieving consistent results. Based on the World Health Organization’s recommended

procedure for conducting visual inspection with acetic acid (VIA), the kit contains all the necessary elements required for the procedure to be done by a healthcare professional in a primary healthcare setting.

These VIA kits have been used in clinical trials in India and the findings are positive, for both patient and practitioner. The kit makes it easy for screening centers to manage multiple aspects such as ensuring consistency and quality of the kit’s components as well as confirming that all active ingredients are sourced from FDA or ISO-approved facilities. This also ensures the validation process is consistent, as each kit uses identical components.

Early detection can save countless lives around the world.

VIA is an attractive alternative to cytology-based screening, especially in limited-resource areas. This simple and safe cervical cancer screening technique simplifies the process and is simply more feasible and more acceptable to women as well as providers in these particular areas.

Several long-term studies have been conducted around the world that ultimately show the effectiveness of the VIA-based screening approach. In India, for example, cervical cancer mortality was reduced by 31% over a period of 15 years among women screened with VIA.

ADVANCED

VIA KIT

ADVANCED VIA KIT

Safe and reliable.

Dalrada Health’s enhanced single-use disposable advanced VIA kit features components manufactured in FDA-approved facilities that are sterilized and standardized in order to prevent cross-contamination with the goal of achieving consistent results. Based on the World Health Organization’s recommended procedure for conducting visual inspection with acetic acid (VIA), the kit contains all the necessary elements required for the procedure to be done by a healthcare professional in a primary healthcare setting.

These VIA kits have been used in clinical trials in India and the findings are positive, for both patient and practitioner. The kit makes it easy for screening centers to manage multiple aspects such as ensuring consistency and quality of the kit’s components as well as confirming that all active ingredients are sourced from FDA or ISO-approved facilities. This also ensures the validation process is consistent, as each kit uses identical components.

Early detection can save countless lives around the world.

VIA is an attractive alternative to cytology-based screening, especially in limited-resource areas. This simple and safe cervical cancer screening technique simplifies the process and is simply more feasible and more acceptable to women as well as providers in these particular areas.

Several long-term studies have been conducted around the world that ultimately show the effectiveness of the VIA-based screening approach. In India, for example, cervical cancer mortality was reduced by 31% over a period of 15 years among women screened with VIA.

ADVANCED

VIA KIT

ADVANCED VIA KIT

Safe and reliable.

Dalrada Health’s enhanced single-use disposable advanced VIA kit features components manufactured in FDA-approved facilities that are sterilized and standardized in order to prevent cross-contamination with the goal of achieving consistent results. Based on the World Health Organization’s recommended

procedure for conducting visual inspection with acetic acid (VIA), the kit contains all the necessary elements required for the procedure to be done by a healthcare professional in a primary healthcare setting.

These VIA kits have been used in clinical trials in India and the findings are positive, for both patient and practitioner. The kit makes it easy for screening centers to manage multiple aspects such as ensuring consistency and quality of the kit’s components as well as confirming that all active ingredients are sourced from FDA or ISO-approved facilities. This also ensures the validation process is consistent, as each kit uses identical components.

Early detection can save countless lives around the world.

VIA is an attractive alternative to cytology-based screening, especially in limited-resource areas. This simple and safe cervical cancer screening technique simplifies the process and is simply more feasible and more acceptable to women as well as providers in these particular areas.

Several long-term studies have been conducted around the world that ultimately show the effectiveness of the VIA-based screening approach. In India, for example, cervical cancer mortality was reduced by 31% over a period of 15 years among women screened with VIA.